[HTML][HTML] Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa
A Leach, J Vekemans, M Lievens, O Ofori-Anyinam… - Malaria journal, 2011 - Springer
Abstract Background GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative
are working in partnership to develop a malaria vaccine to protect infants and children living …
are working in partnership to develop a malaria vaccine to protect infants and children living …
[HTML][HTML] Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa
A Leach, J Vekemans, M Lievens… - Malaria …, 2011 - ncbi.nlm.nih.gov
Background GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are
working in partnership to develop a malaria vaccine to protect infants and children living in …
working in partnership to develop a malaria vaccine to protect infants and children living in …
Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa
A Leach, J Vekemans, M Lievens, O Ofori-Anyinam… - Malaria Journal, 2011 - go.gale.com
Background GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are
working in partnership to develop a malaria vaccine to protect infants and children living in …
working in partnership to develop a malaria vaccine to protect infants and children living in …
[HTML][HTML] Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa
A Leach, J Vekemans, M Lievens… - Malaria …, 2011 - malariajournal.biomedcentral.com
GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are working in
partnership to develop a malaria vaccine to protect infants and children living in malaria …
partnership to develop a malaria vaccine to protect infants and children living in malaria …
Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
A Leach, J Vekemans, M Lievens, O Ofori-Anyinam… - Malaria …, 2011 - europepmc.org
Background GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are
working in partnership to develop a malaria vaccine to protect infants and children living in …
working in partnership to develop a malaria vaccine to protect infants and children living in …
Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa
A Leach, J Vekemans, M Lievens… - Malaria …, 2011 - pubmed.ncbi.nlm.nih.gov
Background GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are
working in partnership to develop a malaria vaccine to protect infants and children living in …
working in partnership to develop a malaria vaccine to protect infants and children living in …
Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa
A Leach, J Vekemans, M Lievens… - Malaria …, 2011 - researchers.cdu.edu.au
Background: GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are
working in partnership to develop a malaria vaccine to protect infants and children living in …
working in partnership to develop a malaria vaccine to protect infants and children living in …
Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa
A Leach, J Vekemans, M Lievens… - Malaria …, 2011 - search.proquest.com
Background GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are
working in partnership to develop a malaria vaccine to protect infants and children living in …
working in partnership to develop a malaria vaccine to protect infants and children living in …
Design of a phase iii multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
A Leach, J Vekemans, M Lievens, O Ofori-Anyinam… - 2011 - cabidigitallibrary.org
Abstract Background: GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative
are working in partnership to develop a malaria vaccine to protect infants and children living …
are working in partnership to develop a malaria vaccine to protect infants and children living …
Design of a phase III multicenter trial to evaluate the efficacy of the RTS, S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
A Leach, J Vekemans, M Lievens… - MALARIA …, 2011 - researchonline.lshtm.ac.uk
BACKGROUND: GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are
working in partnership to develop a malaria vaccine to protect infants and children living in …
working in partnership to develop a malaria vaccine to protect infants and children living in …